These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 30764770)

  • 1. The role of extended-spectrum cephalosporin-resistance in recurrent community-onset Enterobacteriaceae urinary tract infections: a retrospective cohort study.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler M; Tolomeo P; Han JH;
    BMC Infect Dis; 2019 Feb; 19(1):163. PubMed ID: 30764770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Omorogbe J; Dankwa L; Wheeler MK; Tolomeo P; Han JH;
    Infect Control Hosp Epidemiol; 2018 Dec; 39(12):1431-1435. PubMed ID: 30375298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.
    Anesi JA; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Wheeler M; Tolomeo P; Han JH
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1433-1439. PubMed ID: 27678022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency Department Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common.
    Frazee BW; Trivedi T; Montgomery M; Petrovic DF; Yamaji R; Riley L
    Ann Emerg Med; 2018 Oct; 72(4):449-456. PubMed ID: 29980462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the risk factors for recurrent UTI with repeated ESBL-producing Enterobacteriaceae? A retrospective cohort study.
    Ahn ST; Lee HS; Han DE; Lee DH; Kim JW; Park MG; Park HS; Moon DG; Oh MM
    J Infect Chemother; 2023 Jan; 29(1):72-77. PubMed ID: 36195248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study.
    Kung CH; Ku WW; Lee CH; Fung CP; Kuo SC; Chen TL; Lee YT
    J Microbiol Immunol Infect; 2015 Apr; 48(2):168-74. PubMed ID: 24064292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Clinical Prediction Tool for Extended-Spectrum Cephalosporin Resistance in Community-Onset Enterobacterales Urinary Tract Infection.
    Weinstein EJ; Han JH; Lautenbach E; Nachamkin I; Garrigan C; Bilker WB; Dankwa L; Wheeler M; Tolomeo P; Anesi JA;
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz164. PubMed ID: 31041359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary Tract Infections Caused by Community-Acquired Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a Level III Hospital - A Retrospective Study].
    Simões A; Lima M; Brett A; Queiroz C; Chaves C; Oliveira H; Januário L; Rodrigues F
    Acta Med Port; 2020 Jul; 33(7-8):466-474. PubMed ID: 31962058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence.
    Pilmis B; Scemla A; Join-Lambert O; Mamzer MF; Lortholary O; Legendre C; Zahar JR
    Infect Dis (Lond); 2015; 47(10):714-8. PubMed ID: 26024285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
    Boix-Palop L; Xercavins M; Badía C; Obradors M; Riera M; Freixas N; Pérez J; Rodríguez-Carballeira M; Garau J; Calbo E
    Int J Antimicrob Agents; 2017 Aug; 50(2):197-202. PubMed ID: 28552471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections.
    Wong CP; Delate T; Hudson E; Nguyen JK; Yang SJ; Abraham M
    BMC Infect Dis; 2021 Aug; 21(1):823. PubMed ID: 34399680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for urinary tract infection caused by Enterobacteriaceae with extended-spectrum beta-lactamase resistance in patients admitted to internal medicine departments.
    Vardi M; Kochavi T; Denekamp Y; Bitterman H
    Isr Med Assoc J; 2012 Feb; 14(2):115-8. PubMed ID: 22693794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Tüzün T; Sayın Kutlu S; Kutlu M; Kaleli İ
    Turk J Med Sci; 2019 Aug; 49(4):1206-1211. PubMed ID: 31385490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Characterization of Extended-Spectrum β-Lactamase
    Shash RY; Elshimy AA; Soliman MY; Mosharafa AA
    Am J Trop Med Hyg; 2019 Mar; 100(3):522-528. PubMed ID: 30594263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
    Kim SA; Altshuler J; Paris D; Fedorenko M
    Int J Antimicrob Agents; 2018 Jan; 51(1):155-158. PubMed ID: 28943367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we consider faecal colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae in empirical therapy of community-onset sepsis?
    Stupica D; Lusa L; Klevišar MN; Terzić S; Pirš M; Premru MM; Strle F
    Int J Antimicrob Agents; 2017 Oct; 50(4):564-571. PubMed ID: 28711676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Third-Generation Cephalosporin Resistance and Associated Discordant Antibiotic Treatment in Emergency Department Febrile Urinary Tract Infections.
    Mark DG; Hung YY; Salim Z; Tarlton NJ; Torres E; Frazee BW
    Ann Emerg Med; 2021 Sep; 78(3):357-369. PubMed ID: 33781606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis.
    Alevizakos M; Nasioudis D; Mylonakis E
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased antibiotic susceptibility of Enterobacteriaceae causing community-acquired urinary tract infections in French Amazonia.
    Baizet C; Ouar-Epelboin S; Walter G; Mosnier E; Moreau B; Djossou F; Epelboin L
    Med Mal Infect; 2019 Feb; 49(1):63-68. PubMed ID: 30385068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children.
    Megged O
    Pediatr Nephrol; 2014 Sep; 29(9):1583-7. PubMed ID: 24705795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.